Free Trial

Vincerx Pharma (VINC) Insider Trading & Ownership

Vincerx Pharma logo
$0.15 0.00 (-3.15%)
Closing price 04:00 PM Eastern
Extended Trading
$0.13 -0.02 (-11.19%)
As of 07:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vincerx Pharma (NASDAQ:VINC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
15.60%
Number Of
Insiders Buying
(Last 3 Years)
5
Amount Of
Insider Buying
(Last 3 Years)
$231,545.04
Number Of
Insiders Selling
(Last 3 Years)
0
Get VINC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vincerx Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VINC Insider Buying and Selling by Quarter

Vincerx Pharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/11/2023Alexander A SeelenbergerInsiderBuy10,500$0.95$9,975.00  
8/9/2023Ahmed Md HamdyInsiderBuy16,900$0.95$16,055.00  
12/14/2022Ahmed Md HamdyCEOBuy35,280$0.87$30,693.60  
12/14/2022Raquel E IzumiInsiderBuy28,738$0.88$25,289.44  
8/24/2022Christopher P LoweDirectorBuy18,400$1.65$30,360.00  
6/27/2022Raquel E IzumiInsiderBuy40,000$1.41$56,400.00  
6/23/2022Ahmed Md HamdyCEOBuy24,200$1.41$34,122.00  
6/9/2022Laura I BushnellDirectorBuy15,000$1.91$28,650.00  
(Data available from 1/1/2013 forward)

VINC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Vincerx Pharma includes Ahmed Md Hamdy, Alexander A Seelenberger, Christopher P Lowe, Laura I Bushnell, and Raquel E Izumi. Learn more on insiders at VINC.

15.60% of Vincerx Pharma stock is owned by insiders. Learn more on VINC's insider holdings.

The following insiders have purchased VINC shares in the last 24 months: Ahmed Md Hamdy ($16,055.00), and Alexander A Seelenberger ($9,975.00).

Insiders have purchased a total of 27,400 VINC shares in the last 24 months for a total of $26,030.00 bought.

Vincerx Pharma Key Executives



This page (NASDAQ:VINC) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners